{"draw":1,"recordsFiltered":13121,"recordsTotal":13121,"data":[{"__attributes":{"id":"post-row-88744","class":"post-row post-type-post post-88744 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png\" class=\"\" alt=\"FDA Advisory No.2024-1089 || Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)\" loading=\"lazy\" title=\"FDA Advisory No.2024-1089\" data-caption=\"FDA Advisory No.2024-1089 || Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1089-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1089-pilot-implementation-of-the-food-and-drug-administration-fda-eservices-portal-system-for-the-initial-application-of-a-certificate-of-medical-device-notification-cmdn-w\/\">FDA Advisory No.2024-1089 || Pilot Implementation of the Food and Drug Administration (FDA) eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN) within the National Capital Region (NCR)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88736","class":"post-row post-type-post post-88736 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1079-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" loading=\"lazy\" title=\"1079-A\" data-caption=\"FDA Advisory No.2024-1079-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1079-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1079-a-babala-sa-publiko-tungkol-sa-paggamit-ng-mga-sumusunod-na-beripikadong-pekeng-gamot-na\/\">FDA Advisory No.2024-1079-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>, <a href=\"https:\/\/www.fda.gov.ph\/category\/uncategorized\/\" rel=\"category tag\">Uncategorized<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88725","class":"post-row post-type-post post-88725 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png\" class=\"\" alt=\"FDA Advisory No.2024-1079 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1079\" data-caption=\"FDA Advisory No.2024-1079 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1079-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1079-public-health-warning-against-the-purchase-and-use-of-the-following-verified-counterfeit-drug-products\/\">FDA Advisory No.2024-1079 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88721","class":"post-row post-type-post post-88721 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1073-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1073-A\" data-caption=\"FDA Advisory No.2024-1073-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1073-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-carbocisteine-solmux-500-mg-capsule\/\">FDA Advisory No.2024-1073-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88717","class":"post-row post-type-post post-88717 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png\" class=\"\" alt=\"FDA Advisory No.2024-1073 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1073\" data-caption=\"FDA Advisory No.2024-1073 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1073-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1073-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-carbocisteine-solmux-500-mg-capsule\/\">FDA Advisory No.2024-1073 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cCarbocisteine (Solmux\u00ae) 500 mg Capsule\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88712","class":"post-row post-type-post post-88712 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1076-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1076-A\" data-caption=\"FDA Advisory No.2024-1076-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1076-a-babala-sa-publiko-tungkol-sa-paggamit-ng-mga-sumusunod-na-beripikadong-pekeng-gamot-na\/\">FDA Advisory No.2024-1076-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88707","class":"post-row post-type-post post-88707 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png\" class=\"\" alt=\"FDA Advisory No.2024-1076 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1076\" data-caption=\"FDA Advisory No.2024-1076 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1076-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1076-public-health-warning-against-the-purchase-and-use-of-the-following-verified-counterfeit-drug-products\/\">FDA Advisory No.2024-1076 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88699","class":"post-row post-type-post post-88699 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1075-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1075-A\" data-caption=\"FDA Advisory No.2024-1075-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1075-a-babala-sa-publiko-tungkol-sa-paggamit-ng-mga-sumusunod-na-beripikadong-pekeng-gamot-na\/\">FDA Advisory No.2024-1075-A || Babala sa Publiko tungkol sa Paggamit ng mga sumusunod na Beripikadong Pekeng Gamot na:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88692","class":"post-row post-type-post post-88692 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1078-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1078-A\" data-caption=\"FDA Advisory No.2024-1078-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1078-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1078-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88688","class":"post-row post-type-post post-88688 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png\" class=\"\" alt=\"FDA Advisory No.2024-1075 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1075\" data-caption=\"FDA Advisory No.2024-1075 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1075-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1075-public-health-warning-against-the-purchase-and-use-of-the-following-verified-counterfeit-drug-products\/\">FDA Advisory No.2024-1075 || Public Health Warning Against the Purchase and Use of the following Verified Counterfeit Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88683","class":"post-row post-type-post post-88683 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png\" class=\"\" alt=\"FDA Advisory No.2024-1078 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1078\" data-caption=\"FDA Advisory No.2024-1078 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1078-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1078-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1078 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88679","class":"post-row post-type-post post-88679 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1074-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1074-A\" data-caption=\"FDA Advisory No.2024-1074-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1074-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1074-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88677","class":"post-row post-type-post post-88677 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1077-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1077-A\" data-caption=\"FDA Advisory No.2024-1077-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1077-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-loperamide-hydrochloride-diatabs-2-mg-capsule\/\">FDA Advisory No.2024-1077-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88670","class":"post-row post-type-post post-88670 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png\" class=\"\" alt=\"FDA Advisory No.2024-1074 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1074\" data-caption=\"FDA Advisory No.2024-1074 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1074-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1074-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1074 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88669","class":"post-row post-type-post post-88669 publish"},"date":" 7 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png\" class=\"\" alt=\"FDA Advisory No.2024-1077 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1077\" data-caption=\"FDA Advisory No.2024-1077 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/FDA-Advisory-No.2024-1077-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1077-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-loperamide-hydrochloride-diatabs-2-mg-capsule\/\">FDA Advisory No.2024-1077 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cLoperamide Hydrochloride (Diatabs\u00ae) 2 mg Capsule\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88615","class":"post-row post-type-post post-88615 publish"},"date":" 6 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png\" class=\"\" alt=\"FDA Advisory No.2024-1081 || REMINDERS TO THE GENERAL PUBLIC ON CHOOSING A PEST CONTROL OPERATOR (PCO)\" loading=\"lazy\" title=\"1081\" data-caption=\"FDA Advisory No.2024-1081 || REMINDERS TO THE GENERAL PUBLIC ON CHOOSING A PEST CONTROL OPERATOR (PCO)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1081-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1081-reminders-to-the-general-public-on-choosing-a-pest-control-operator-pco\/\">FDA Advisory No.2024-1081 || REMINDERS TO THE GENERAL PUBLIC ON CHOOSING A PEST CONTROL OPERATOR (PCO)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88603","class":"post-row post-type-post post-88603 publish"},"date":" 6 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png\" class=\"\" alt=\"FDA Advisory No.2024-1083 || REITERATION OF FDA CIRCULAR 2012-014 ENTITLED  \u201cDISPOSITION OF FLOOD-AFFECTED HEALTH PRODUCTS\u201d\" loading=\"lazy\" title=\"1083\" data-caption=\"FDA Advisory No.2024-1083 || REITERATION OF FDA CIRCULAR 2012-014 ENTITLED  \u201cDISPOSITION OF FLOOD-AFFECTED HEALTH PRODUCTS\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1083-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1083-reiteration-of-fda-circular-2012-014-entitled-disposition-of-flood-affected-health-products\/\">FDA Advisory No.2024-1083 || REITERATION OF FDA CIRCULAR 2012-014 ENTITLED  \u201cDISPOSITION OF FLOOD-AFFECTED HEALTH PRODUCTS\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/general-advisories\/\" rel=\"category tag\">General Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88567","class":"post-row post-type-post post-88567 publish"},"date":" 5 August 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png\" class=\"\" alt=\"FDA Advisory No.2024-1082 || Clarification on the Jurisdiction of the Food and Drug Administration on Veterinary Drug Products\" loading=\"lazy\" title=\"1082\" data-caption=\"FDA Advisory No.2024-1082 || Clarification on the Jurisdiction of the Food and Drug Administration on Veterinary Drug Products\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/08\/1082-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1082-clarification-on-the-jurisdiction-of-the-food-and-drug-administration-on-veterinary-drug-products\/\">FDA Advisory No.2024-1082 || Clarification on the Jurisdiction of the Food and Drug Administration on Veterinary Drug Products<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88479","class":"post-row post-type-post post-88479 publish"},"date":" 31 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" class=\"\" alt=\"FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS - ME-6058 Containing Banned Ingredient\" loading=\"lazy\" title=\"FDA Advisory No.2024-1060\" data-caption=\"FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS - ME-6058 Containing Banned Ingredient\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1060-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1060-public-health-warning-against-the-purchase-and-use-of-cosmetic-product-meiya-matte-lipgloss-me-6058-containing-banned-ingredient\/\">FDA Advisory No.2024-1060 || Public Health Warning Against the Purchase and Use of Cosmetic Product MEIYA MATTE LIPGLOSS &#8211; ME-6058 Containing Banned Ingredient<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88459","class":"post-row post-type-post post-88459 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1013-A\" data-caption=\"FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1013-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1013-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88455","class":"post-row post-type-post post-88455 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" class=\"\" alt=\"FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1013\" data-caption=\"FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1013-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1013-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-paracetamol-biogesic-500-mg-tablet\/\">FDA Advisory No.2024-1013 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cParacetamol (Biogesic\u00ae) 500 mg Tablet\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88451","class":"post-row post-type-post post-88451 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1008-A\" data-caption=\"FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1008-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-ms-miao-skin-firster-15g\/\">FDA Advisory No.2024-1008-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cMS\u00ae Miao Skin Firster 15g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88447","class":"post-row post-type-post post-88447 publish"},"date":" 30 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" class=\"\" alt=\"FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1008\" data-caption=\"FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1008-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1008-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-ms-miao-skin-firster-15g\/\">FDA Advisory No.2024-1008 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cMS\u00ae Miao Skin Firster 15g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88391","class":"post-row post-type-post post-88391 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1011-A\" data-caption=\"FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1011-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1011-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88387","class":"post-row post-type-post post-88387 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" class=\"\" alt=\"FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1011\" data-caption=\"FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1011-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1011-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1011 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88383","class":"post-row post-type-post post-88383 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1010-A\" data-caption=\"FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1010-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1010-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88379","class":"post-row post-type-post post-88379 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" class=\"\" alt=\"FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1010\" data-caption=\"FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1010-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1010-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1010 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88375","class":"post-row post-type-post post-88375 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1009-A\" data-caption=\"FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1009-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1009-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88371","class":"post-row post-type-post post-88371 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" class=\"\" alt=\"FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1009\" data-caption=\"FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1009-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1009-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1009 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88367","class":"post-row post-type-post post-88367 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1007-A\" data-caption=\"FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1007-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-verapamil-hci-injection-usp-5-mg-2-5-mg-ml-2-ml\/\">FDA Advisory No.2024-1007-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88363","class":"post-row post-type-post post-88363 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" class=\"\" alt=\"FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1007\" data-caption=\"FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1007-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1007-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-verapamil-hci-injection-usp-5-mg-2-5-mg-ml-2-ml\/\">FDA Advisory No.2024-1007 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cVerapamil HCI Injection USP 5 mg (2.5 mg\/mL) 2 mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88359","class":"post-row post-type-post post-88359 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1005-A\" data-caption=\"FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1005-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1005-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88355","class":"post-row post-type-post post-88355 publish"},"date":" 29 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" class=\"\" alt=\"FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1005\" data-caption=\"FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1005-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1005-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1005 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88350","class":"post-row post-type-post post-88350 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1019-A\" data-caption=\"FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1019-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1019-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88346","class":"post-row post-type-post post-88346 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" class=\"\" alt=\"FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1019\" data-caption=\"FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1019-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1019-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1019 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88342","class":"post-row post-type-post post-88342 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1018-A\" data-caption=\"FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1018-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1018-A || \t Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88338","class":"post-row post-type-post post-88338 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" class=\"\" alt=\"FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1018\" data-caption=\"FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1018-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1018-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1018 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88334","class":"post-row post-type-post post-88334 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1016-A\" data-caption=\"FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1016-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-care-of-your-health-alcohol-pads-saturated-with-70-isopropyl-alcohol-100-pcs\/\">FDA Advisory No.2024-1016-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88330","class":"post-row post-type-post post-88330 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" class=\"\" alt=\"FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1016\" data-caption=\"FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1016-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1016-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-care-of-your-health-alcohol-pads-saturated-with-70-isopropyl-alcohol-100-pcs\/\">FDA Advisory No.2024-1016 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cCare of Your Health Alcohol Pads Saturated with 70% Isopropyl Alcohol 100 Pcs\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88325","class":"post-row post-type-post post-88325 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1015-A\" data-caption=\"FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1015-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-round-pink-coated-tablets-50s\/\">FDA Advisory No.2024-1015-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cRound Pink Coated Tablets 50\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88321","class":"post-row post-type-post post-88321 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" class=\"\" alt=\"FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-1015\" data-caption=\"FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1015-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1015-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-round-pink-coated-tablets-50s\/\">FDA Advisory No.2024-1015 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cRound Pink Coated Tablets 50\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88317","class":"post-row post-type-post post-88317 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1014-A\" data-caption=\"FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1014-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1014-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88313","class":"post-row post-type-post post-88313 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" class=\"\" alt=\"FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1014\" data-caption=\"FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1014-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1014-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1014 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88309","class":"post-row post-type-post post-88309 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" class=\"\" alt=\"FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1012-A\" data-caption=\"FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1012-a-pinapayuhan-ng-food-and-drug-administration-fda-ang-publiko-laban-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-1012-A || Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88305","class":"post-row post-type-post post-88305 publish"},"date":" 26 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" class=\"\" alt=\"FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-1012\" data-caption=\"FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1012-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1012-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-1012 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88254","class":"post-row post-type-post post-88254 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" class=\"\" alt=\"FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;JUDAH PREMIUM ORGANICS CASTOR OIL&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1054\" data-caption=\"FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;JUDAH PREMIUM ORGANICS CASTOR OIL&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1054-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1054-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-judah-premium-organics-castor-oil\/\">FDA Advisory No.2024-1054 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;JUDAH PREMIUM ORGANICS CASTOR OIL&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88252","class":"post-row post-type-post post-88252 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" class=\"\" alt=\"FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NISCE SKIN BASICS ANTI-ACNE SOAP&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1062\" data-caption=\"FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;NISCE SKIN BASICS ANTI-ACNE SOAP&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1062-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1062-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-nisce-skin-basics-anti-acne-soap\/\">FDA Advisory No.2024-1062 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;NISCE SKIN BASICS ANTI-ACNE SOAP&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88246","class":"post-row post-type-post post-88246 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" class=\"\" alt=\"FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING MIX LOTION SPF 50&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1053\" data-caption=\"FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;HEROLISA&#039;S WHITENING MIX LOTION SPF 50&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1053-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1053-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-herolisas-whitening-mix-lotion-spf-50\/\">FDA Advisory No.2024-1053 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;HEROLISA&#8217;S WHITENING MIX LOTION SPF 50&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88242","class":"post-row post-type-post post-88242 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" class=\"\" alt=\"FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;V&amp;M NATURALS EMU OIL LIP SUNSCREEN - SMOOCH LIP DETOX&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1061\" data-caption=\"FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &quot;V&amp;M NATURALS EMU OIL LIP SUNSCREEN - SMOOCH LIP DETOX&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1061-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1061-public-health-warning-against-the-purchase-and-use-of-unnotified-cosmetic-vm-naturals-emu-oil-lip-sunscreen-smooch-lip-detox\/\">FDA Advisory No.2024-1061 || Public Health Warning Against the Purchase and Use of Unnotified Cosmetic &#8220;V&#038;M NATURALS EMU OIL LIP SUNSCREEN &#8211; SMOOCH LIP DETOX&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-88238","class":"post-row post-type-post post-88238 publish"},"date":" 22 July 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" class=\"\" alt=\"FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-1052\" data-caption=\"FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &quot;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/07\/FDA-Advisory-No.2024-1052-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-1052-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-ellen-ella-tone-up-sunscreen-spf50-pa-uva-uvb\/\">FDA Advisory No.2024-1052 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic &#8220;ELLEN ELLA TONE UP SUNSCREEN SPF50 PA+++ UVA\/UVB&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""}]}
